Craniopharyngioma, Child Clinical Trial
Official title:
Advancing Treatment for Pediatric Craniopharyngioma: Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy
New data suggests that the current treatment for pediatric adamantinomatous craniopharyngioma (CPA) may not be as effective as it could be.
Current treatment regimens for pediatric CPA are limited to surgery and radiation therapy. This pilot study seeks to identify biologically rational therapeutics for the medical treatment of adamantinomatous CPA by confirming the overexpression of specific molecules. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05465174 -
Nivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
|
Phase 2 |